Can the Mediterranean diet decrease the chances of gestational diabetes and preeclampsia?

When using monitored glucose values to alter treatment plans, patients with type 1 diabetes may need to change their monitoring regimen. 

Patients spent more time in target glycemic range with closed-loop system versus sensor-augmented insulin pump

Plans often deviate from recommended criteria for coverage; some insurers categorically deny access

Our former intern, Amber Satz, PharmD Candidate, LECOM School of Pharmacy, was reviewing some info on GLP-1 Analogs and came across a new entry into the class. Efpeglenatide is a new weekly analog from Sanofi. It appears to be as effective as all other weekly’s out there, and it will …

Last week I saw a patient who seemed to be losing control of her blood glucose levels. She had been doing well and her A1c had been around 6.0 - 6.3 for the past couple of years. She was doing this while only on metformin 1000 twice a day. She was referred to me by her physician because of high after-meal readings ranging up to 350 mg/dl. I went over her medical history and medications looking for a possible problem and found nothing.

Can the Freestyle Libre Flash glucose monitoring system perform accurately when challenged?

Efpeglenatide, a new GLP-1 receptor agonist, referenced to liraglutide in Phase II trial.

Can resistance training improve beta-cell function in patients with prediabetes?

Annals of Internal Medicine study claims the health threat from red, processed meat is overstated